Business Description
Pharmadrug Inc
NAICS : 325411
SIC : 3741
ISIN : CA5134413031
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | -1.42 | |||||
Debt-to-Equity | -1.04 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -5.6 | |||||
3-Year EPS without NRI Growth Rate | 48.3 | |||||
3-Year FCF Growth Rate | 48.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.25 | |||||
9-Day RSI | 23.14 | |||||
14-Day RSI | 28.82 | |||||
6-1 Month Momentum % | -60.67 | |||||
12-1 Month Momentum % | -59.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.22 | |||||
Quick Ratio | 0.22 | |||||
Cash Ratio | 0.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.7 | |||||
Shareholder Yield % | -27.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.21 | |||||
EV-to-EBITDA | -0.21 | |||||
EV-to-FCF | -6.64 | |||||
Earnings Yield (Greenblatt) % | -476.19 | |||||
FCF Yield % | -32.86 |